Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew McSoley

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Ophthalmic Inflammation and Infection|May 8, 2026
Comparative long-term outcomes of conventional immunomodulatory therapy, biologic agents, and combination therapy in chronic uveitisCharles Zhang, Matthew McSoley, Sinan Ersan, et al.
The Ocular Surface|May 30, 2020
The role of Th17 immunity in chronic ocular surface disordersNai-Wen Fan, Thomas H Dohlman, William Foulsham, et al.
Ophthalmology|March 31, 2022
Bevacizumab in High-Risk Corneal Transplantation: A Pilot Multicenter Prospective Randomized Control TrialThomas H Dohlman, Matthew McSoley, Francisco Amparo, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Ophthalmic Inflammation and Infection|May 8, 2026
Comparative long-term outcomes of conventional immunomodulatory therapy, biologic agents, and combination therapy in chronic uveitisCharles Zhang, Matthew McSoley, Sinan Ersan, et al.
The Ocular Surface|May 30, 2020
The role of Th17 immunity in chronic ocular surface disordersNai-Wen Fan, Thomas H Dohlman, William Foulsham, et al.
Ophthalmology|March 31, 2022
Bevacizumab in High-Risk Corneal Transplantation: A Pilot Multicenter Prospective Randomized Control TrialThomas H Dohlman, Matthew McSoley, Francisco Amparo, et al.
Pageof 1